Erenumab For Treatment of Hemicrania Continua

NCT04303845 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped difficulty with recruitment

Conditions

Interventions

Sponsor

Mayo Clinic